See up to 3 months of RXST. The 7-day demo opens the 1M and 3M ranges and puts RXST on your watchlist.
Start 7-day demoLatest RXST insider trades
About RxSight, Inc. (RXST)
The SEC lists RxSight, Inc. under CIK 0001111485, in ophthalmic goods. We track it alongside the rest of the Health Care sector.
RXST Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 16,947 | $118K |
| Grant or award | 17 | 4,526,748 | |
| Option exercise | 10 | 159,548 | |
RXST insider transactions (Form 4)
8153 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Eric Weinberg - Officer | Option exercise | Common Stock | 35,168 | $4.34 | $153K | |
| Eric Weinberg - Officer | Option exercise | Stock Option (right to buy) | 35,168 | $0.00 | - | |
| Mark Wilterding - Officer | Derivative | Stock Option (right to buy) | 258,770 | - footnote F2 | - | |
| Mark Wilterding - Officer | Grant or award | Stock Option (right to buy) | 258,770 | - footnote F2 | - | |
| ||||||
| Eric Weinberg - Officer | Derivative | Stock option (right to buy) | 87,437 | - footnote F1 | - | |
| Eric Weinberg - Officer | Derivative | Stock Option (right to buy) | 95,000 | - footnote F3 | - | |
| Eric Weinberg - Officer | Derivative | Stock Option (right to buy) | 92,200 | - footnote F5 | - | |
| Eric Weinberg - Officer | Derivative | Stock Option (right to buy) | 50,000 | - footnote F5 | - | |
| Eric Weinberg - Officer | Derivative | Stock Option (right to buy) | 125,000 | - footnote F1 | - | |
| Eric Weinberg - Officer | Grant or award | Stock Option (right to buy) | 65,742 | - footnote F1 | - | |
| Eric Weinberg - Officer | Grant or award | Stock Option (right to buy) | 82,608 | - footnote F3 | - | |
| Eric Weinberg - Officer | Grant or award | Stock Option (right to buy) | 59,483 | - footnote F5 | - | |
| Eric Weinberg - Officer | Grant or award | Stock Option (right to buy) | 32,258 | - footnote F5 | - | |
| Eric Weinberg - Officer | Grant or award | Stock Option (right to buy) | 93,984 | - footnote F1 | - | |
| ||||||
| Derivative | Stock option (right to buy) | 338,819 | - footnote F1 | - | ||
| Derivative | Stock Option (right to buy) | 200,000 | - footnote F3 | - | ||
| Derivative | Stock Option (right to buy) | 149,000 | - footnote F5 | - | ||
| Derivative | Stock Option (right to buy) | 215,000 | - footnote F1 | - | ||
| Grant or award | Stock Option (right to buy) | 254,751 | - footnote F1 | - | ||
| Grant or award | Stock Option (right to buy) | 173,913 | - footnote F3 | - | ||
| Grant or award | Stock Option (right to buy) | 96,129 | - footnote F5 | - | ||
| Grant or award | Stock Option (right to buy) | 161,654 | - footnote F1 | - | ||
| ||||||
| Ilya Goldshleger - Officer | Derivative | Stock option (right to buy) | 98,367 | - footnote F1 | - | |
| Ilya Goldshleger - Officer | Derivative | Stock Option (right to buy) | 120,000 | - footnote F3 | - | |
| Ilya Goldshleger - Officer | Derivative | Stock Option (right to buy) | 92,200 | - footnote F5 | - | |
| Ilya Goldshleger - Officer | Derivative | Stock Option (right to buy) | 50,000 | - footnote F5 | - | |
| Ilya Goldshleger - Officer | Derivative | Stock Option (right to buy) | 125,000 | - footnote F1 | - | |
| Ilya Goldshleger - Officer | Grant or award | Stock Option (right to buy) | 73,960 | - footnote F1 | - | |
| Ilya Goldshleger - Officer | Grant or award | Stock Option (right to buy) | 104,347 | - footnote F3 | - | |
| Ilya Goldshleger - Officer | Grant or award | Stock Option (right to buy) | 59,483 | - footnote F5 | - | |
| Ilya Goldshleger - Officer | Grant or award | Stock Option (right to buy) | 32,258 | - footnote F5 | - | |
| Ilya Goldshleger - Officer | Grant or award | Stock Option (right to buy) | 93,984 | - footnote F1 | - | |
| ||||||
| Option exercise | Common Stock | 13,425 | - footnote F1 | - | ||
| Open-market sale | Common Stock | 5,100 | $6.96 | $35K | ||
| Option exercise | Restricted Stock Unit | 13,425 | $0.00 | - | ||
| ||||||
| Mark Wilterding - Officer | Option exercise | Common Stock | 20,441 | - footnote F1 | - | |
| Mark Wilterding - Officer | Open-market sale | Common Stock | 7,765 | $6.96 | $54K | |
| Mark Wilterding - Officer | Option exercise | Restricted Stock Unit | 20,441 | $0.00 | - | |
| ||||||
| Ilya Goldshleger - Officer | Option exercise | Common Stock | 5,370 | - footnote F1 | - | |
| Ilya Goldshleger - Officer | Open-market sale | Common Stock | 2,041 | $6.96 | $14K | |
| Ilya Goldshleger - Officer | Option exercise | Restricted Stock Unit | 5,370 | $0.00 | - | |
| ||||||
| Eric Weinberg - Officer | Option exercise | Common Stock | 5,370 | - footnote F1 | - | |
| Eric Weinberg - Officer | Open-market sale | Common Stock | 2,041 | $6.96 | $14K | |
| Eric Weinberg - Officer | Option exercise | Restricted Stock Unit | 5,370 | $0.00 | - | |
| ||||||
| Aziz Mottiwala - Officer | Grant or award | Restricted Stock Unit | 2,312,138 | $0.00 | - | |
| Aziz Mottiwala - Officer | Grant or award | Stock Option (right to buy) | 571,286 | $0.00 | - | |
| Robert Keith Warner | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Robert J. Palmisano | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Shweta Maniar | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Tamara Fountain | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| William J. Phd Link | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Jesse Anderson Corley | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Grant or award | Common Stock | 30,864 footnote F2 | - footnote F1 | - | ||
| ||||||
| Bakker Juliet Tammenoms | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Julie Andrews | Grant or award | Common Stock | 37,037 footnote F2 | - footnote F1 | - | |
| ||||||
| Ilya Goldshleger - Officer | Option exercise | Common Stock | 12,489 | $4.13 | $52K | |
| Ilya Goldshleger - Officer | Option exercise | Stock Option (right to buy) | 12,489 | $0.00 | - | |
| Mark Wilterding - Officer | Tax withholding / forfeiture | Common Stock | 8,068 | $7.61 | $61K | |
| Mark Wilterding - Officer | Option exercise | Common Stock | 20,441 | - footnote F1 | - | |
| Mark Wilterding - Officer | Option exercise | Restricted Stock Unit | 20,441 | $0.00 | - | |
| ||||||
| Scott Gaines - Officer | Option exercise | Restricted Stock Unit | 604 | $0.00 | - | |
| Scott Gaines - Officer | Option exercise | Restricted Stock Unit | 1,250 | $0.00 | - | |
| Scott Gaines - Officer | Option exercise | Restricted Stock Unit | 1,250 | $0.00 | - | |
| Scott Gaines - Officer | Option exercise | Restricted Stock Unit | 1,657 | $0.00 | - | |
| Scott Gaines - Officer | Option exercise | Common Stock | 6,261 | - footnote F1 | - | |
| Scott Gaines - Officer | Tax withholding / forfeiture | Common Stock | 2,580 | $7.61 | $20K | |
| Scott Gaines - Officer | Grant or award | Restricted Stock Unit | 32,218 | $0.00 | - | |
| Scott Gaines - Officer | Option exercise | Restricted Stock Unit | 1,500 | $0.00 | - | |
| ||||||
| Ilya Goldshleger - Officer | Grant or award | Restricted Stock Unit | 32,218 | $0.00 | - | |
| Eric Weinberg - Officer | Grant or award | Restricted Stock Unit | 32,218 | $0.00 | - | |
| Grant or award | Restricted Stock Unit | 80,545 | $0.00 | - | ||
| Mark Wilterding - Officer | Grant or award | Stock Option (right to buy) | 258,770 | $0.00 | - | |
| Mark Wilterding - Officer | Grant or award | Restricted Stock Unit | 163,528 | $0.00 | - | |
| Ilya Goldshleger - Officer | Option exercise | Common Stock | 15,096 | $4.34 | $66K | |
| Ilya Goldshleger - Officer | Option exercise | Common Stock | 8,349 | $4.13 | $34K | |
| Ilya Goldshleger - Officer | Option exercise | Stock Option (right to buy) | 5,416 | $0.00 | - | |
| Ilya Goldshleger - Officer | Option exercise | Stock Option (right to buy) | 9,680 | $0.00 | - | |
| Ilya Goldshleger - Officer | Option exercise | Stock Option (right to buy) | 8,349 | $0.00 | - | |
| Grant or award | Common Stock | 35,668 | $0.00 | - | ||
| William J. Phd Link | Grant or award | Common Stock | 10,752 | - | - | |
| Tamara Fountain | Grant or award | Common Stock | 10,752 | - | - | |
Recent RXST Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Kurtz Ronald M MD | Officer | 5,100 | $35K | View on EDGAR | |
| Weinberg Eric | Officer | 2,041 | $14K |
RXST insider trading FAQ
What is the latest insider trade for RXST?
RxSight, Inc. (RXST) had 10 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for RXST runs to 53 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RXST stock?
No insider purchases of RXST were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling RXST stock?
4 insider sales of RXST were filed in the last 90 days, totaling $118K.
Where can I see RXST SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RXST Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Eric Weinberg view on EDGAR
- - Mark Wilterding view on EDGAR
- - Eric Weinberg view on EDGAR
- - Ronald M. Md Kurtz view on EDGAR
- - Ilya Goldshleger view on EDGAR
- - Ronald M. Md Kurtz view on EDGAR
- - Mark Wilterding view on EDGAR
- - Ilya Goldshleger view on EDGAR
- - Eric Weinberg view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where RXST's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RXST with a 7-day demo
- RXST on your watchlist
- Every RXST Form 4 filing on record
- Up to 3 months of RXST price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive